GM3 synthase as a therapeutic target in microvascular complications of diabetes

Details for Australian Patent Application No. 2005240714 (hide)

Owner Merck Patent GmbH

Inventors Wiernsperger, Nicolas; Troncy, Lysiane; Lagarde, Michel; Ruggiero, Daniel; Elbawab, Samer; Masson, Elodie

Agent Davies Collison Cave

Pub. Number AU-B-2005240714

PCT Pub. Number WO2005/108600

Priority 0404971 07.05.04 FR; 0413530 17.12.04 FR

Filing date 7 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 7 July 2011

International Classifications

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/108600 Priority application(s): WO2005/108600

7 July 2011 Application Accepted

  Published as AU-B-2005240714

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240730-Disc brake

2005240691-Recombinant chemokine-antigen vaccine